Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Comment by radcaton Oct 30, 2022 10:07am
40 Views
Post# 35058441

RE:Div makes this attractive

RE:Div makes this attractiveI am a new shareholder. Bought my shares a few days before the Sept 29th, the ex-dividend date. What I liked about SNN was...
Covid-19 was made public on Jan 25th 2020, SNN share price on Jan 26th 2020 closed at $50.57. The high for the past year Nov 5th 2021 was $37.15. Both past share prices make SNN + dividend seem like a bargain. We all saw our hospitals over capacity with ill covid patients, while others who needed surgery, hips and knees for example, were delayed indefinitely. Brexit, Covid-19, and British Parliament shenanigans have also contributed negatively to the share price. Going forward Smith & Nephew should see their business take a turn for the better providing we do not see a repeat of Covid. Will buy more shares when I can.   
<< Previous
Bullboard Posts
Next >>